Articles from Adverse Event Reporting News (September 21, 2010)

Title	Author	Type	Words
Abbott recalls some HIV screening tests.		Brief article	199
AdvaMed says 510(k) program is just fine as is.			342
Allergan settles Botox off-label marketing charges.			969
AngioSculpt 'EX' PTCA Scoring Balloon Catheter recalled.		Brief article	146
BagEasy manual resuscitation devices recalled.		Brief article	182
Bone drugs linked to risk of esophageal tumors, thigh fractures.			722
CHMP meets to discuss Avandia and Pandemrix.		Brief article	163
Court awards couple $1.5 million against Davol.			487
DEA heads first-ever nationwide prescription drug take-back day.			374
Disclose large-scale adverse events, AHRQ study advises.			505
Drug information from pharmacies found lacking, study says.			660
Eli Lilly gets reversal of ruling granting class-action status for Zyprexa lawsuit.		Brief article	286
FDA advisory committee votes against approving lorcaserin, splits on Meridia.			1333
FDA delays decision on Avastin for breast cancer.			351
FDA honors Kelsey for thalidomide role and advancing drug safety.			498
FDA panel says cough medicines should remain OTC.		Brief article	298
FDA reviewing preliminary safety information on Actos.		Brief article	179
FDA to review medical products alongside Medicare.		Brief article	142
FDA wants second look at needleless connectors.			360
FDA: new warnings required on use of gadolinium-based contrast agents.			394
Fingerstick devices should never be used for more than one person: FDA.		Brief article	298
Forest to pay $300 million in penalties for marketing violations, blocking FDA inspection.			497
HHS' Corrigan to join FDA as Associate Commissioner for Regulatory Affairs.		Brief article	197
Hospira Symbiq Infusers subject to Class I recall.		Brief article	136
Hypertension meds may raise blood pressure in some patients.			761
Look-alike tubes threaten patient safety.			1403
Maquet recalls Hemashield devices.		Brief article	198
New dosing guide issued for children using Valcyte.		Brief article	300
New iPhone app tracks drug safety.		Brief article	171
Novacare recalls products containing undeclared drug ingredient.		Brief article	193
Outgunned FDA tries to get tough with drug ads.			1368
Pittsburgh firm uses RFID to track surgical sponges left in the body.		Brief article	256
Warning system may help protect elderly patients: study.		Brief article	244